Dr Edward Emmott BSc (Hons), PhD
Lecturer Biochemistry & Systems Biology
- +44 (0)151 795 1232 Ext. 1232
- Work email E.Emmott@liverpool.ac.uk
- Personal WebsiteLab Website
RNA virus replication & Single-cell proteomics
Within an infected cell, most of what the virus needs to replicate and produce more virus it takes from the host cell. These can be resources such as tRNA, nucleotides, or large protein complexes such as the ribosome that the virus can use or modify for its own purposes. However, the machinery necessary to replicate the virus genome has to be provided by the virus as this is not a process that occurs within a normal uninfected cell. In the case of positive-sense RNA viruses, initial translation of the viral genome by the ribosome produces the proteins needed for viral replication. This is most commonly in the form of a viral polyprotein.
RNA virus replication is very error-prone compared to DNA replication, so RNA viruses have developed a number of means to compress the maximum amount of protein-coding information into a very small genome. A very common method is for a positive-sense virus to produce a polyprotein. This is a long protein containing a number of different functional domains, separated by protease cleavage sites. The protease is typically contained as part of this polyprotein. Over the course of infection, the polyprotein is cleaved by the protease, with different sites cleaved at different rates. The different cleavage products produced by this process (called precursors) can have different functions depending on their current cleavage state. For example, different precursor forms of the protease can localize to different parts of the cell, controlling when cleavage takes place. As a result, the composition of the viral replication complex, comprising both the viral and cellular proteins needed to replicate the viral genome changes over time, and these changes can be linked to changes in replication complex function.
In the Emmott lab, we are interested in these dynamic changes in replication complex composition throughout infection, and how these can be linked to altered replication complex function. We are also interested in how heterogenous this process is on a single-cell level. Whilst single-cell RNAseq has begun to be applied to studies of virus replication, it cannot give insight into post-translational events such as the protein cleavage that is critical in these polyprotein-based systems. We instead apply single-cell proteomics, using the SCoPE2 method Ed helped develop in his time in the Slavov Lab, alongside more traditional mass spectrometry, virology, mol. bio. and imaging approaches to investigate this phenomena.
Viral proteases and their targets
As described in the section above on RNA virus replication, many positive-sense RNA viruses replicate through the use of polyprotein, which is cleaved by a viral protease. However, it is common for viral proteases to also target cellular proteins for cleavage, and this can play an important role in the viruses ability to take over cellular functions, and hinder an infected cells attempts to resist infection or signal neighboring cells.
Viral proteases can cleave cellular proteins to subvert cellular processes such as protein synthesis, cutting off the host cells ability to make its own protein while leaving all the necessary machinery present to make viral proteins. Similarly, cellular proteins important for immune signaling can be cleaved as a mechanism to inhibit the immune response.
In the lab, we are interested in identifying cellular targets of viral proteases. We are also interested in their cleavage dynamics throughout infection, and how this is regulated by different forms of the viral protease(s). We will be applying mass spectrometry-based approaches to track cleavage over time, identify protease substrates, and monitor subcellular localization. These will be used alongside more traditional microscopy-based and mol. bio. approaches.
Viral interactions with ribosomes
Protein synthesis is a highly regulated process, which ultimately results in the production of proteins by a structure called the ribosome. The textbook model gives the ribosome a largely passive role in the regulation of this process. However, more recent studies have suggested that within mammalian cells, a range of ribosomes with varied protein and RNA composition and modifications may exist, with these having specific roles in protein synthesis. Ed recently published on how specialized ribosomes may function, and how we can prove and characterize their existence (Emmott, Jovanovic & Slavov 2018, Emmott, Jovanovic & Slavov 2019).
In the Emmott lab we are interested in identifying if and how viral infection modifies the core ribosomal protein composition of ribosomes, and the functional consequences of these changes. We discuss the types of approaches we use in detail in Emmott, Jovanovic & Slavov 2018.
Uncovering cellular substrates of 3C-like proteases to identify conserved virus-host interactions as antiviral targets
MEDICAL RESEARCH COUNCIL
November 2022 - November 2025
A cellenONE BSC to enhance UK capability for single-cell proteomics
BIOTECHNOLOGY & BIOLOGICAL SCIENCE RESEARCH COUNCIL
July 2022 - July 2023
REIMS Proof of Concept - Age Grading Mosquitoes
INNOVATIVE VECTOR CONTROL CONSORTIUM (IVCC) - (UK)
April 2021 - December 2022
The utility of sputum proteomics to test response to CFTR modulator therapy
NORTH WEST LUNG CENTRE CHARITY (UK)
January 2022 - January 2024
Understanding proteolytic cleavage of host proteins during avian coronavirus infection
HOUGHTON TRUST (UK)
October 2021 - September 2022
COVID-19: Molecular mapping of SARS-Cov2 and the host response with multiomics mass spectrometry to stratify disease outcomes for therapeutic and diagnostic interventions.
UK RESEARCH AND INNOVATION
October 2020 - April 2022
Investigating the role of GOLGA3 cleavage during SARS-CoV-2 infection
March 2021 - March 2022
Exploiting and advancing single-cell proteomics to identify novel pathways to disrupt RNA virus infection.
THE ACADEMY OF MEDICAL SCIENCES (UK)
May 2021 - May 2024
Ultra-sensitive Proteomics Platform
BIOTECHNOLOGY & BIOLOGICAL SCIENCE RESEARCH COUNCIL
August 2020 - August 2021